Medline Inc. Class A Common Stock (MDLN)vsZEN Graphene Solutions Ltd (ZTEK)
MDLN
Medline Inc. Class A Common Stock
$42.03
-1.06%
HEALTHCARE · Cap: $34.68B
ZTEK
ZEN Graphene Solutions Ltd
$0.57
-2.75%
HEALTHCARE · Cap: $63.02M
Smart Verdict
WallStSmart Research — data-driven comparison
Medline Inc. Class A Common Stock generates 3015342% more annual revenue ($28.43B vs $942,880). MDLN leads profitability with a 4.1% profit margin vs 0.0%. MDLN earns a higher WallStSmart Score of 52/100 (C-).
MDLN
Buy52
out of 100
Grade: C-
ZTEK
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+32.7%
Fair Value
$66.92
Current Price
$42.03
$24.89 discount
Intrinsic value data unavailable for ZTEK.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Revenue surging 73.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
ROE of 6.5% — below average capital efficiency
4.1% margin — thin
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -56.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MDLN
Revenue growth of 14.8% demonstrates continued momentum.
Bull Case : ZTEK
The strongest argument for ZTEK centers on Revenue Growth, Debt/Equity. Revenue growth of 73.1% demonstrates continued momentum.
Bear Case : MDLN
The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.
Bear Case : ZTEK
The primary concerns for ZTEK are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
MDLN profiles as a value stock while ZTEK is a hypergrowth play — different risk/reward profiles.
ZTEK is growing revenue faster at 73.1% — sustainability is the question.
ZTEK generates stronger free cash flow (-2M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MDLN scores higher overall (52/100 vs 23/100) and 14.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medline Inc. Class A Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.
Visit Website →ZEN Graphene Solutions Ltd
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ZEN Graphene Solutions Ltd (ZTEK) is a pioneering company in the field of materials technology, dedicated to the development and commercialization of graphene-based solutions that enhance a wide array of industrial applications. With its innovative proprietary extraction techniques, ZTEK produces high-purity graphene from natural graphite, aiming to revolutionize sectors such as environmental remediation, energy storage, and advanced manufacturing. The company’s robust focus on sustainability and continuous investment in research and development underscores its commitment to leading the graphene technology market. As ZTEK navigates opportunities for growth and innovation, it stands well-positioned to drive long-term shareholder value and meet the rising global demand for high-performance materials.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?